DrugPatentWatch Database Preview

EFFEXOR XR Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

When do Effexor Xr patents expire, and what generic alternatives are available?

Effexor Xr is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in EFFEXOR XR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.

Summary for EFFEXOR XR

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	14
Bulk Api Vendors:	87
Clinical Trials:	56
Patent Applications:	1,661
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for EFFEXOR XR
DailyMed Link:	EFFEXOR XR at DailyMed

Pharmacology for EFFEXOR XR

Drug Class	Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of Action	Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors

Medical Subject Heading (MeSH) Categories for EFFEXOR XR

Antidepressive Agents, Second-Generation

Serotonin and Noradrenaline Reuptake Inhibitors

Synonyms for EFFEXOR XR

(+-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride

(+/-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride

(+/-)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride

(R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride

(RS)-1-(2-Dimethylamino-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride

(RS)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE

1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol hydrochloride

1-(2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-cyclohexanol hydrochloride

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, hcl

1-[2-Dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride

1-[2-Dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexanol -HCl

93413-69-5 (Parent)

99300-78-4

A845995

AB0012466

AB2000111

AC-1696

AC1L1Y1S

AK326210

akos 92111

AKOS000280874

AKOS016340594

AN-14687

ANW-42650

API0004582

BC208275

BG0478

Bio-0110

BVF-012

C17H27NO2.HCl

CAS-99300-78-4

CCG-100979

CCG-213270

CHEBI:9944

CHEMBL1201066

CPD000469154

CS-2130

CTK5I0329

Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride

d,l-venlafaxine, hydrochloride

D00821

Dobupal

DSSTox_CID_27397

DSSTox_GSID_47397

DSSTox_RID_82318

DTXSID8047397

Efexor

Efexor XL

Effexor

Effexor (TN)

Effexor LP

Effexor XL

Effexor;Effexor XR;Efexor

FT-0642395

H13V695

HSDB 6699

HY-B0196A

I01-1036

J10231

KB-08072

KM3503

KS-00000WXA

KS-5049

LP00449

LS-57096

MCULE-5156532617

MFCD03658865

MLS001401454

MolPort-003-987-504

NC00229

NCGC00256703-01

NCGC00261134-01

NSC-745751

NSC745751

PF-00345408

PW-4112

QYRYFNHXARDNFZ-UHFFFAOYSA-N

s1441

SAM001246572

SC-23352

SCHEMBL41936

SMR000469154

TL8006063

Tox21_302508

Tox21_500449

TR-030420

Trevilor

Vandral

Venlafaxin HCL

Venlafaxine (hydrochloride)

Venlafaxine EA

Venlafaxine for system suitability, European Pharmacopoeia (EP) Reference Standard

VENLAFAXINE HCl

Venlafaxine Hydorchloride

venlafaxine hydro chloride

Venlafaxine hydrochloride

Venlafaxine hydrochloride (JAN/USAN)

Venlafaxine hydrochloride [USAN:USP]

Venlafaxine hydrochloride [USAN]

Venlafaxine Hydrochloride 1.0 mg/ml in Methanol (as free base)

Venlafaxine hydrochloride, >=98% (HPLC), powder

Venlafaxine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Venlafaxine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur

Venlafaxine hydrochloride, United States Pharmacopeia (USP) Reference Standard

Venlafaxine XR

Venlafaxinehydrochloride

Wy 45030

Wy-45,030

Wy-45,030 Hcl; 9490-3

Wy-45030

US Patents and Regulatory Information for EFFEXOR XR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-001	Oct 20, 1997	AB	RX	Yes	No
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-004	Oct 20, 1997	AB	RX	Yes	Yes
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-002	Oct 20, 1997	AB	RX	Yes	No
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-003	Oct 20, 1997		DISCN	No	No

  Purchase this report

or, see our see our flat-rate plans

Expired US Patents for EFFEXOR XR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-001	Oct 20, 1997
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-004	Oct 20, 1997
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-004	Oct 20, 1997
Wyeth Pharms Inc	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-004	Oct 20, 1997

Paragraph IV (Patent) Challenges for EFFEXOR XR

Drugname	Dosage	Strength	RLD	Submissiondate
	Extended-release Tablets	37.5 mg, 75 mg and 150 mg		2007-05-03

  Purchase this report

or, see our see our flat-rate plans